Physician profile
Allison Dozeman
NPI 1356684567
$2,801.58
in general payments reported to CMS, 2019-2025
4 companies · $10.25 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.14 · 2021: $140 · 2022: $1,629 · 2023: $177 · 2024: $783 · 2025: $10.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Travel and Lodging: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.28 |
| Travel and Lodging | $392.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,757.07 | 2019-2024 | Bun-Yo-Matic, Portfolio, Hammertube |
| Depuy Synthes Sales INC. | $20.82 | 2023 | Motoband, Minibunion |
| Smith+Nephew, INC. | $13.44 | 2021 | |
| Orthofix Medical, INC. | $10.25 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Dozeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.